Gene expression in bladder cancer and normal tissues

Bladder cancer and normal tissues

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN10601218

Enrollment

Registered

2025-02-26

Start date

2022-05-11

Completion date

Unknown

Last updated

2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer Cancer

Interventions

This study enrols patients with bladder cancer, collects tissue samples at the time of surgery, and follows them for 6 years. Patients are followed up annually by telephone for survival. Cancerous an

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with bladder cancer

Exclusion criteria

Exclusion criteria: Patients with other cancers

Design outcomes

Primary

Measure	Time frame
Survival measured using data collected at an annual telephone call for 6 years	—

Secondary

Measure	Time frame
Transfer or not measured using data collected during a telephone call every 6 months	—

Countries

China

Contacts

Public ContactShufang;Mei Zhang;Chen

;

zsf_99900023@csu.edu.cn;meichen_cns@163.com+86 089866289665;+86 15243653187

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026